BTIG Expands Healthcare Research Team with Biotechnology Analyst Ling Wang

NEW YORK–(BUSINESS WIRE)– BTIG,
LLC, a global financial services firm specializing in
institutional trading, investment banking, research and related
brokerage services, announced today that Ling Wang, CFA has joined the
firm as a Director and Biotechnology Research Analyst in New York.

Ms. Wang has more than 15 years of experience in biotechnology research,
having analyzed companies within the sector for several global financial
services firms in a variety of roles. Most recently, she was a Senior
Research Analyst at Oppenheimer & Co. Earlier in her career, she
conducted research at Memorial Sloan-Kettering Cancer Center,
participating in clinical trials as part of a team that evaluated cancer
vaccines. At BTIG, Ms. Wang’s coverage will focus on biotechnology
companies, industry trends and the competitive landscape. Biotechnology
research represents an important focus within the firm’s healthcare
research offering.

“Complementing the diverse and rapidly expanding healthcare research
coverage of our other team members, Ling greatly enhances BTIG’s
expertise in the biotechnology space,” said Karen Blando, Managing
Director and Director of Research at BTIG. “Ling’s experience
evaluating biotechnology companies, across broad therapeutic areas in
pre-clinical and clinical programs, will be tremendously valuable to our
clients.”

About BTIG

BTIG is a global financial services firm specializing in institutional
trading, investment banking, research and related brokerage services.
With an extensive global footprint and more than 500 employees, BTIG,
LLC and its affiliates operate out of 14 cities in North America,
Europe, Asia and Australia. BTIG offers execution, expertise and
insights for equities, equity derivatives, ETFs, fixed income, futures,
commodities, foreign exchange, interest rates, credit, and convertible
and preferred securities. The company’s core capabilities include global
sales, portfolio, electronic and outsource trading, transition
management, investment banking, prime brokerage, capital introduction,
corporate access, research and strategy, commission management and more.
Disclaimer: https://www.btig.com/Disclaimer.aspx

View source version on businesswire.com: http://www.businesswire.com/news/home/20160523005411/en/